Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Certain classes of genes in patients that could lead to prostate cancer

Dr Erica Golemis - Fox Chase Cancer Center, Philadelphia, USA
Certain classes of genes in patients that could lead to prostate cancer ( Dr Erica Golemis - Fox Chase Cancer Center, Philadelphia, USA )
1 May 2015

New T cell–based immunotherapy shows promise for lethal stem cell transplant complication

Dr Susan Prockop - Memorial Sloan Kettering Cancer Center, New York, USA
New T cell–based immunotherapy shows promise for lethal stem cell transplant complication ( Dr Susan Prockop - Memorial Sloan Kettering Cancer Center, New York, USA )
1 May 2015

Investigational PD-L1–targeted immunotherapy safe for patients with triple-negative breast cancer

Prof Leisha Emens - Johns Hopkins Kimmel Cancer Center, Baltimore, USA
Investigational PD-L1–targeted immunotherapy safe for patients with triple-negative breast cancer ( Prof Leisha Emens - Johns Hopkins Kimmel Cancer Center, Baltimore, USA )
1 May 2015

Pembrolizumab found to be safe with durable responses in advanced non-small cell lung cancer

Dr Edward Garon - David Geffen School of Medicine at the University of California, Los Angeles, USA
Pembrolizumab found to be safe with durable responses in advanced non-small cell lung cancer ( Dr Edward Garon - David Geffen School of Medicine at the University of California, Los Angeles, USA )
1 May 2015

PARP inhibitor combo shows early promise for patients with and without BRCA mutations

Dr Timothy Yap - Royal Marsden Hospital, London, UK
PARP inhibitor combo shows early promise for patients with and without BRCA mutations ( Dr Timothy Yap - Royal Marsden Hospital, London, UK )
1 May 2015

Phase III trial shows pembrolizumab preferable to ipilimumab in advanced melanoma

Prof Antoni Ribas - UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA
Phase III trial shows pembrolizumab preferable to ipilimumab in advanced melanoma ( Prof Antoni Ribas - UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA )
1 May 2015

Long-term, regular aspirin use modestly decreased cancer risk

Prof Andrew Chan - Harvard Medical School and Massachusetts General Hospital, Boston USA
Long-term, regular aspirin use modestly decreased cancer risk ( Prof Andrew Chan - Harvard Medical School and Massachusetts General Hospital, Boston USA )
1 May 2015

Phase II trial of ipilimumab-nivolumab combo shows promise in advanced melanoma

Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA
Phase II trial of ipilimumab-nivolumab combo shows promise in advanced melanoma ( Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA )
1 May 2015

US breast cancer cases expected to increase by as much as 50 percent

Dr Phillip Rosenberg - Division of Cancer Epidemiology and Genetics, National Cancer Institute, USA
US breast cancer cases expected to increase by as much as 50 percent ( Dr Phillip Rosenberg - Division of Cancer Epidemiology and Genetics, National Cancer Institute, USA )
1 May 2015

Investigational ER degrader safe, with early signs of antitumour activity against advanced ER-positive breast cancer

Dr Maura Dickler - Memorial Sloan Kettering Cancer Center, New York, USA
Investigational ER degrader safe, with early signs of antitumour activity against advanced ER-positive breast cancer ( Dr Maura Dickler - Memorial Sloan Kettering Cancer Center, New York, USA )
1 May 2015

New immunotherapy yields long-lasting responses in some patients with advanced melanoma

Dr Mark Middleton - University of Oxford, Oxford, UK
New immunotherapy yields long-lasting responses in some patients with advanced melanoma ( Dr Mark Middleton - University of Oxford, Oxford, UK )
30 Apr 2015

How is ganetespib regulating the response of tumour cells in lung cancer?

Dr Erica Golemis - Fox Chase Cancer Center, Philadelphia, USA
How is ganetespib regulating the response of tumour cells in lung cancer? ( Dr Erica Golemis - Fox Chase Cancer Center, Philadelphia, USA )
30 Apr 2015